Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2122 Views
-
Last post by frodo
-
- 0 Replies
- 9502 Views
-
Last post by NHE
-
- 2 Replies
- 1599 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1757 Views
-
Last post by Petr75
-
- 0 Replies
- 1194 Views
-
Last post by NHE
-
- 2 Replies
- 1839 Views
-
Last post by frodo
-
- 0 Replies
- 10381 Views
-
Last post by NHE
-
- 0 Replies
- 2471 Views
-
Last post by frodo
-
- 0 Replies
- 2534 Views
-
Last post by NHE